mild to moderate COVID-19 patients COVID-19 Thai recipies Molnupiravir
Conditions
Interventions
2 capsules three times a day (400 mg/capsule) for 5 days,Molnupiravir 4 capsule (200 mg/capsule) twice a day for 5 days
Experimental Drug,Active Comparator Drug
Thai recipes,control
Sponsors
NCRT
Eligibility
Sex/Gender
All
Age
20 Years to 60 Years
Inclusion criteria
Inclusion criteria: 1 mild to moderate COVID-19 patients age 20-60 year old 2. no severe or uncontrolled underlying disease 3. no history of herb allergy 4. understand Thai language 5. able to sign inform consent form
Exclusion criteria
Exclusion criteria: 1. RT-PCR negative for COVID-19 or viral load at day 0 is untectable 2. unconciousness patient or glasgow coma scalte less than14 3.patient whose vital signs are unstable (blood pressure less than 90/60, puls rate more than 100/min 4.patient need ventilator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| number of viral load day0, day3, day6 real time PCR,symptoms day0,day1,day2,day3,day4,day5,day6 questionare,Serum interleukin-6 day0,day3,day6 ELISA technique | — |
Secondary
| Measure | Time frame |
|---|---|
| liver function test day0, day3,day6 laboratory lab test,Renal function test day0, day3,day6 laboratory lab test,complete blood count day0,day3,day6 laboratory lab test | — |
Countries
Thailand
Contacts
Public Contactsaranypain potikanond
Faculty of Medicine, Chiang Mai University
Outcome results
None listed